BioCentury
ARTICLE | Company News

BTG, Eisai sales and marketing update

February 10, 2014 8:00 AM UTC

Eisai launched DC Bead in Japan as a device for transcatheter arterial embolization (TAE) therapy in patients with hepatocellular carcinoma (HCC). Additionally, Eisai said the device was classified i...